Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Daiichi Sankyo
Cipla
Julphar
Citi
Teva
Fish and Richardson
Mallinckrodt
Medtronic

Generated: January 18, 2018

DrugPatentWatch Database Preview

Bitolterol mesylate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for bitolterol mesylate and what is the scope of bitolterol mesylate patent protection?

Bitolterol mesylate
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for bitolterol mesylate

US Patents and Regulatory Information for bitolterol mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us TORNALATE bitolterol mesylate AEROSOL, METERED;INHALATION 018770-001 Dec 28, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us TORNALATE bitolterol mesylate SOLUTION;INHALATION 019548-001 Feb 19, 1992 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for bitolterol mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us TORNALATE bitolterol mesylate AEROSOL, METERED;INHALATION 018770-001 Dec 28, 1984 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us TORNALATE bitolterol mesylate AEROSOL, METERED;INHALATION 018770-001 Dec 28, 1984 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us TORNALATE bitolterol mesylate SOLUTION;INHALATION 019548-001 Feb 19, 1992 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us TORNALATE bitolterol mesylate SOLUTION;INHALATION 019548-001 Feb 19, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Moodys
Boehringer Ingelheim
McKinsey
Baxter
Mallinckrodt
Johnson and Johnson
UBS
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot